If you loved our Explainer on Engineering Biology, you'll love this new summarised version. This short report takes you through the key BIA member companies working in the AMR space, and explains the cutting-edge work taking place in the UK.
There are a number of significant moving pieces right now in the sector, including the major strategic shift at UKRI and Innovate launched last Thursday.
BIA BioSolutions is here: a new strategic platform dedicated to championing the UK’s engineering biology ecosystem beyond health. Discover how we are bridging the gap between world-class science and industrial scale to drive global sustainability.
Salvivo has been awarded £99,080 in Innovate UK Analysis for Innovators funding to enable evaluation of its FishburneTabs™ platform for biomarker detection with the National Physical Laboratory (NPL).
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA.
PrecisionLife and Ovation announce results of first phase to develop drug-response biomarkers to quantitively predict the efficacy, safety and tolerability of glucagon-like peptide-1 receptor agonist (GLP-1).
